Reference
Horton L, et al. Central nervous system t cell lymphoproliferative disease following treatment with alemtuzumab. Neurology 92 (Suppl.): no pagination abstr. P4.2-020, No. 15, 09 Apr 2019. Available from: URL: https://n.neurology.org/content/92/15_Supplement/P4.2-020 - USA
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1776, 25 (2019). https://doi.org/10.1007/s40278-019-70183-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-70183-2